Currently the Enterprise Value (EV) is not available for Barinthus Biotherapeutics.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 8.03,
with a Debt / Equity ratio of 0.09.
8.03
8.03
0.09
-0.22
-0.4
-1282.45
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$142.56K
$-581.66K
105
0.09
n/a
Taxes
-44K
0.07%
Stock Price Statistics
The stock price has increased by -5.47% in the
last 52 weeks. The beta is -0.74, so Barinthus Biotherapeutics's
price volatility has been lower than the market average.
-0.74
-5.47%
1.26
1.03
49.93
1,252,216
Income Statement
In the last 12 months, Barinthus Biotherapeutics had revenue of 14.97M
and earned -61.07M
in profits. Earnings per share was -1.55.